Octave Specialty Group (OSG) Set to Post Quarterly Earnings on Monday

Key Points

• Octave Specialty Group is expected to report Q3 2026 results after Monday’s market close, with analysts forecasting a loss of $0.06 per share and revenue of $23.22 million. The earnings call is scheduled for Tuesday, November 10, at 8:30 a.m. ET.
• The company’s previous quarter fell short of expectations, reporting a $0.04-per-share loss versus the projected $0.01 loss, despite revenue of $83.0 million. Octave posted a negative net margin of 51.10%.
• Analyst sentiment is mixed, with a consensus rating of “Hold” and an average price target of $11.50; the stock recently opened at $5.04 and has traded between $3.88 and $10.38 over the past year.

Octave Specialty Group (NYSE:OSG - Get Free Report) is projected to release its Q3 2026 results after the market closes on Monday, November 9th. Analysts expect Octave Specialty Group to announce earnings of ($0.06) per share and revenue of $23.22 million for the quarter. Individuals can find conference call details on the company's upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Tuesday, November 10, 2026 at 8:30 AM ET.

Octave Specialty Group (NYSE:OSG - Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported ($0.04) earnings per share for the quarter, missing analysts' consensus estimates of ($0.01) by ($0.03). The business had revenue of $83.00 million during the quarter, compared to analyst estimates of $22.79 million. Octave Specialty Group had a negative net margin of 51.10% and a positive return on equity of 0.44%. On average, analysts expect Octave Specialty Group to post $0.19 EPS for the current fiscal year and $0.55 EPS for the next fiscal year.

Octave Specialty Group Stock Performance

Shares of OSG opened at $5.04 on Monday. The firm's 50 day moving average is $4.61 and its 200-day moving average is $5.22. The stock has a market capitalization of $227.05 million, a P/E ratio of -1.38 and a beta of 0.76. The company has a debt-to-equity ratio of 0.19, a current ratio of 0.92 and a quick ratio of 0.92. Octave Specialty Group has a 12-month low of $3.88 and a 12-month high of $10.38.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the stock. Zacks Research lowered shares of Octave Specialty Group from a "hold" rating to a "strong sell" rating in a research report on Monday, October 5th. Weiss Ratings upgraded Octave Specialty Group from a "sell (e+)" rating to a "sell (d-)" rating in a research report on Wednesday, October 21st. Finally, Keefe, Bruyette & Woods initiated coverage on Octave Specialty Group in a research note on Friday, August 28th. They set an "outperform" rating and a $8.00 price objective for the company. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and two have assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $11.50.

Octave Specialty Group Company Profile

Octave Specialty Group Inc is a specialty insurance company that provides underwriting solutions for complex, specialized and difficult-to-place risks. The company operates through specialty insurance platforms designed to serve customers and distribution partners seeking coverage outside standard commercial insurance markets.

Its business activities include the development, underwriting and management of specialty insurance products across selected lines of business. Octave's offerings are intended for niche risks that may require specialized expertise, tailored policy structures and disciplined risk selection.

The company serves the specialty insurance market through relationships with brokers, agents and other distribution partners.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.